High Point Clinical Trials Center announced a 3-year collaboration with ProSciento to join NASH PASS as a site partner, according to a press release.
NASH PASS is Prosciento’s program designed to combine select qualified sites and a proprietary methodology to improve enrollment outcomes in nonalcoholic steatohepatitis clinical trials.
As a partner in NASH PASS, High Point Clinical Trials Center (HPCTC) will contribute its pharmacology expertise and resources from its database of prospective clinical study participants evaluated for nonalcoholic fatty liver disease and NASH using transient

Source link